PacBio’s very expensive foray into short read sequencing is now officially over. 🙄
www.pacb.com/press_releas...
MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of sel...